Conference Committees

IPVC 2023 Executive Committee

IPVC 2023 Co-Chairs

Suzanne Garland
Australia

Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, Department of Microbiology, RCH Honorary Research Fellow, Murdoch Childrens Research Institute Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia

Toshiyuki Sasagawa
Japan

IPVC 2023 Organizing Committee

Suzanne Garland
Australia

Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, Department of Microbiology, RCH Honorary Research Fellow, Murdoch Childrens Research Institute Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia

Aimee Kreimer
USA

Infectious Disease Epidemiologist
Senior Investigator, Division of Cancer Epidemiology and Genetics
US National Cancer Institute
National Institutes of Health

Takayuki Enomoto
Japan

Margaret Stanley
United Kingdom

Margaret Stanley is Emeritus Professor of Epithelial Biology in the University of Cambridge
and Honorary Fellow of Christs College, Cambridge. She has a lifetime award
for contribution to research on cervical cancer and cervical precancers from the American
Society for Colposcopy and Cytopathology (ASCCP) and a lifetime award for achievement
from the IPVS.

Anna R. Giuliano
USA

Ryo Konno
Japan

Michelle Adair Ozbun
USA

Professor, Departments of Molecular Genetics & Microbiology; Obstetrics and Gynecology, The University of New Mexico School of Medicine Co-Leader, Head and Neck Cancer Clinical Working Group, The University of New Mexico Comprehensive Cancer Center

Toshiyuki Sasagawa
Japan

Kiyoko Kato
Japan

Basic Sciences Track

Tohru Kiyono
Japan

Margaret Stanley
United Kingdom

Margaret Stanley is Emeritus Professor of Epithelial Biology in the University of Cambridge
and Honorary Fellow of Christs College, Cambridge. She has a lifetime award
for contribution to research on cervical cancer and cervical precancers from the American
Society for Colposcopy and Cytopathology (ASCCP) and a lifetime award for achievement
from the IPVS.

John Doorbar
United Kingdom

Clinical Research Track

Kei Kawana
Japan

Anna-Barbara Moscicki
USA

Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine.
Associate Executive Chair for Clinical Research, and Chair, Clinical Trials Committee for Pediatrics

Mayumi Nakagawa
USA

Joakim Dillner
Sweden

Public Health, Epidemiology & Implementation Science Track

Sharon Hanley
Japan

Eduardo Franco
Canada

Ann Burchell
Canada

Dr. Ann Burchell is Research Director at the Department of Family and Community Medicine and Scientist at the MAP Centre for Urban Health Solutions at St. Michael’s Hospital, Toronto. She is a Canada Research Chair in Sexually Transmitted Infection Prevention. She holds degrees in epidemiology from the University of Toronto (MSc) and McGill University (PhD) and has academic appointments as Associate Professor, Department of Family and Community Medicine, Faculty of Medicine, and Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto; Adjunct Professor, Division of Cancer Epidemiology, McGill University; and Adjunct Scientist, Institute for Clinical Evaluative Medicine, Toronto.

Dr. Burchell’s research program focuses on the epidemiology of human immunodeficiency virus (HIV) infection, human papillomavirus (HPV), syphilis, and other sexually transmitted infections (STIs). Its goal is to generate evidence for effective and practical strategies to prevent STIs and STI-related cancers in high-risk populations, including people living with or at risk for HIV.

She has extensive methodological experience in the design and implementation of: observational longitudinal studies with primary and secondary data; sexual behaviour and health-access questionnaires; natural history studies using laboratory markers of infection; and pragmatic randomized trials for HPV prevention and improved screening for syphilis, cervical and anal cancer. She currently holds a Foundation Grant from the Canadian Institutes of Health Research.

Laia Alemany
Spain

Susanne Krüger Kjaer
Denmark

Basic Sciences Workshop Track

Iwao Kukimoto
Japan

Nagayasu Egawa
United Kingdom

M.D., PhD.,
Research Associate,
Department of Pathology,
University of Cambridge

Thomas Broker
USA

Biochemistry & Molecular Genetics
University of Alabama

Clinical Research Workshop Track

Etsuko Miyagi
Japan

Joel Palefsky
USA

M.D., C.M., F.R.C.P.(C). Professor of Medicine at the University of California San Francisco School of Medicine. His interests include the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer. He is the founder and past president of the International Anal Neoplasia Society and is the past president of the International Papillomavirus Society (IPVS). He continues to serve on the board of IPVS and leads the IPVS International HPV Awareness Day Campaign.

Public Health Workshop Track

Yutaka Ueda
Japan

Aimee Kreimer
USA

Infectious Disease Epidemiologist
Senior Investigator, Division of Cancer Epidemiology and Genetics
US National Cancer Institute
National Institutes of Health

Staci Sudenga
USA

CJ Chen
Taiwan

Talía Malagón
Canada

Early Career Researcher Program

Takeo Shibata
Japan

Dorothy Machalek
Australia

Khoo Su Pei
Malaysia

Shangying Hu
China

Talía Malagón
Canada

Hawa Camara
Papua New Guinea

Sofia Tsiapakidou
Greece

Andreia Albuquerque
Portugal

Dipanwita Banerjee
India

Visit 2021 website Membership